SecSonar.com

ProKidney Corp. (PROK)

ProKidney Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ProKidney Corp. (PROK) is a Biotechnology company based in US with a market capitalization of $621.5M. Free cash flow was negative at -$135.3M. This page tracks PROK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 204 employees · IPO Jun 30, 2021

Valuation

Valuation & price

$1.66 · as of May 17, 2026 · -68.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.54$2.57$0.61Jul 25Dec 25Jul 26Jul 7, 25$0.61Jul 9, 25$4.34Jul 11, 25$4.54Jul 15, 25$3.37Jul 17, 25$3.52Jul 21, 25$3.22Jul 23, 25$3.22Jul 25, 25$3.29Jul 29, 25$2.77Jul 31, 25$2.77Aug 4, 25$3.26Aug 6, 25$2.88Aug 11, 25$2.26Aug 13, 25$2.37Aug 15, 25$2.36Aug 19, 25$2.33Aug 21, 25$2.32Aug 25, 25$2.35Aug 27, 25$2.49Aug 29, 25$2.36Sep 3, 25$2.36Sep 5, 25$2.25Sep 9, 25$2.21Sep 11, 25$2.98Sep 16, 25$2.62Sep 18, 25$2.71Sep 22, 25$2.81Sep 24, 25$2.72Sep 26, 25$2.49Sep 30, 25$2.42Oct 2, 25$2.78Oct 6, 25$2.90Oct 8, 25$3.26Oct 10, 25$3.02Oct 14, 25$3.09Oct 16, 25$3.04Oct 21, 25$3.30Oct 23, 25$3.19Oct 27, 25$3.22Oct 29, 25$3.10Oct 31, 25$3.06Nov 4, 25$2.80Nov 6, 25$2.81Nov 10, 25$2.70Nov 12, 25$2.68Nov 14, 25$2.41Nov 18, 25$2.28Nov 20, 25$2.09Nov 25, 25$2.10Nov 28, 25$2.22Dec 2, 25$2.25Dec 4, 25$2.57Dec 8, 25$2.35Dec 10, 25$2.17Dec 12, 25$2.21Dec 16, 25$2.20Dec 18, 25$2.47Dec 22, 25$2.46Dec 24, 25$2.57Dec 29, 25$2.20Jan 2, 26$2.23Jan 6, 26$2.25Jan 8, 26$2.36Jan 12, 26$2.33Jan 14, 26$2.28Jan 16, 26$2.29Jan 21, 26$2.15Jan 23, 26$2.17Jan 27, 26$2.21Jan 29, 26$2.13Feb 2, 26$2.04Feb 4, 26$1.90Feb 9, 26$1.99Feb 11, 26$2.00Feb 13, 26$1.98Feb 18, 26$2.11Feb 20, 26$2.09Feb 24, 26$2.24Feb 26, 26$2.23Mar 2, 26$2.31Mar 4, 26$2.46Mar 6, 26$2.30Mar 10, 26$2.48Mar 12, 26$2.24Mar 17, 26$2.13Mar 19, 26$1.95Mar 23, 26$1.94Mar 25, 26$1.83Mar 27, 26$1.60Mar 31, 26$1.79Apr 2, 26$1.90Apr 7, 26$1.83Apr 9, 26$1.90Apr 13, 26$1.95Apr 15, 26$2.01Apr 17, 26$2.18Apr 22, 26$2.09Apr 24, 26$1.94Apr 28, 26$1.83Apr 30, 26$1.90May 4, 26$1.88May 6, 26$1.96May 8, 26$1.86May 12, 26$1.78May 14, 26$1.71May 18, 26$1.61May 20, 26$1.69May 22, 26$1.75May 28, 26$1.81Jun 1, 26$1.85Jun 3, 26$1.73Jun 5, 26$1.80Jun 9, 26$1.67Jun 11, 26$1.66Jun 15, 26$1.67Jun 17, 26$1.75Jun 22, 26$1.82Jun 24, 26$1.77Jun 26, 26$1.83Jul 2, 26$2.01
$0.6152-week range$5.18
Loading valuation history…

Fundamentals

Key fundamentals

$621.5M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$135.3M

Free cash flow (USD)

-$267.1M

Net debt

Net cash position

36.8%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$76.0KFY 2025$893.0K
$0$893K

Free cash flow by year

2019 → 2025

FY 2019$-78.1KFY 2020$-30.6MFY 2021$-55.5MFY 2022$-78.9MFY 2023$-124.3MFY 2024$-155.9MFY 2025$-135.3M
-$78.1K-$135.3M

Gross margin by year

2024 → 2025

FY 2024100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.14)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 29, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 15, 2026Filing

Questions

Frequently asked questions

What is ProKidney Corp.'s market cap?

ProKidney Corp. (PROK) has a market capitalization of $621.5M.

What is PROK's P/E ratio?

A meaningful P/E ratio is not available for PROK — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did ProKidney Corp. last report earnings?

PROK last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying PROK stock?

SEC Form 4 filings show no open-market insider buys at ProKidney Corp. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

DNA

Ginkgo Bioworks Holdings, Inc.

$628.4M

PRME

Prime Medicine, Inc.

$632.2M

CBIO

Crescent Biopharma, Inc.

$598.3M

BIOA

BioAge Labs, Inc.

$646.1M

ESPR

Esperion Therapeutics, Inc.

$650.8M

ANL

Adlai Nortye Ltd.

$652.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.